Analysis of a Routinely Used Commercial Anti-Chikungunya IgM ELISA Reveals Cross-Reactivities with Dengue in Brazil: A New Challenge for Differential Diagnosis?
- PMID: 33946597
- PMCID: PMC8147240
- DOI: 10.3390/diagnostics11050819
Analysis of a Routinely Used Commercial Anti-Chikungunya IgM ELISA Reveals Cross-Reactivities with Dengue in Brazil: A New Challenge for Differential Diagnosis?
Abstract
In Brazil, chikungunya emerged in 2014, and by 2016, co-circulated with other arbovirosis, such as dengue and zika. ELISAs (Enzyme-Linked Immunosorbent Assays) are the most widely used approach for arboviruses diagnosis. However, some limitations include antibody cross reactivities when viruses belong to the same genus, and sensitivity variations in distinct epidemiological scenarios. As chikungunya virus (CHIKV) is an alphavirus, no serological cross reactivity with dengue virus (DENV) should be observed. Here, we evaluated a routinely used chikungunya commercial IgM (Immunoglobulin M) ELISA test (Anti-Chikungunya IgM ELISA, Euroimmun) to assess its performance in confirming chikungunya in a dengue endemic area. Samples (n = 340) representative of all four DENV serotypes, healthy individuals and controls were tested. The Anti-CHIKV IgM ELISA test had a sensitivity of 100% and a specificity of 25.3% due to the cross reactivities observed with dengue. In dengue acute cases, the chikungunya test showed an overall cross-reactivity of 31.6%, with a higher cross-reactivity with DENV-4. In dengue IgM positive cases, the assay showed a cross-reactivity of 46.7%. Serological diagnosis may be challenging and, despite the results observed here, more evaluations shall be performed. Because distinct arboviruses co-circulate in Brazil, reliable diagnostic tools are essential for disease surveillance and patient management.
Keywords: Brazil; anti-chikungunya IgM ELISA; chikungunya diagnosis; dengue cross-reactivity.
Conflict of interest statement
The authors declare no conflict of interest exists.
Figures
References
-
- de Souza T.M.A., Ribeiro E.D., Corrêa V.C.E., Damasco P.V., Santos C.C., de Bruycker-Nogueira F., Chouin-Carneiro T., Faria N., Nunes P.C.G., Heringer M., et al. Following in the Footsteps of the Chikungunya Virus in Brazil: The First Autochthonous Cases in Amapá in 2014 and Its Emergence in Rio de Janeiro during 2016. Viruses. 2018;10:623. doi: 10.3390/v10110623. - DOI - PMC - PubMed
-
- Santos F.B.D., Filippis A.M.B.D., Araújo E.S.M.D., Lima M.d.R.Q., Nogueira F.D.B., Faria N.R.D.C., Simões J.B.S., Sampaio S.A., Nunes P.C.G., Silva M.H.D., et al. A Review on Dengue Diagnosis and Epidemiology by a Regional Reference Laboratory in 25 years, Rio de Janeiro, Brazil. Dengue Bull. 2013;31:61–76.
-
- Heringer M., Nogueira R.M., de Filippis A.M., Lima M.R., Faria N.R., Nunes P.C., Nogueira F.B., dos Santos F.B. Impact of the emergence and re-emergence of different dengue viruses’ serotypes in Rio de Janeiro, Brazil, 2010 to 2012. Trans. R. Soc. Trop. Med. Hyg. 2015;109:268–274. doi: 10.1093/trstmh/trv006. - DOI - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials
